Table 2

Bivariate and multivariable analyses of the categorical factors associated with fatigue as defined by a Fatigue Severity Scale score ≥4 in the Cohorte Lausannoise (CoLaus) study, Lausanne, Switzerland, 2014–2017

BivariateMultivariable
No fatigueFatigueP valueOR (95% CI)P value
Gender0.031
 Male1066 (47.9)268 (43.0)1 (ref)
 Female1159 (52.1)355 (57.0)1.25 (0.99 to 1.58)0.065
Age group<0.001
 45–54643 (28.9)236 (37.9)1 (ref)
 55–64724 (32.5)209 (33.6)0.69 (0.53 to 0.90)0.006
 64–74626 (28.1)113 (18.1)0.43 (0.31 to 0.59)<0.001
 75+232 (10.4)65 (10.4)0.60 (0.40 to 0.90)0.013
Educational level0.017
 Primary249 (11.2)93 (14.9)1 (ref)
 Apprenticeship794 (35.7)221 (35.5)1.05 (0.73 to 1.51)0.782
 High school626 (28.1)182 (29.2)1.13 (0.78 to 1.64)0.520
 University556 (25.0)127 (20.4)0.98 (0.66 to 1.46)0.937
Smoking categories0.279
 Never907 (41.7)242 (39.7)
 Former866 (39.8)264 (43.4)
 Current402 (18.5)103 (16.9)
BMI categories<0.001
 Underweight37 (1.7)5 (0.8)0.69 (0.24 to 2.01)0.495
 Normal920 (41.4)219 (35.2)1 (ref)
 Overweight914 (41.1)243 (39.0)1.01 (0.78 to 1.31)0.942
 Obese354 (15.9)156 (25.0)1.40 (1.03 to 1.91)0.032
Insomnia categories<0.001
 No insomnia1782 (86.2)335 (62.6)1 (ref)
 Subthreshold233 (11.3)114 (21.3)1.57 (1.16 to 2.13)0.003
 Clinical insomnia53 (2.6)86 (16.1)3.76 (2.41 to 5.86)<0.001
Caffeinated drinks0.147
 None205 (9.5)75 (12.3)
 1–3/day1418 (65.5)374 (61.5)
 4–6/day471 (21.8)137 (22.5)
 7+/day70 (3.2)22 (3.6)
Self-rated health<0.001
 Very good621 (27.9)58 (9.3)1 (ref)
 Good1323 (59.5)294 (47.2)1.94 (1.39 to 2.71)<0.001
 Average270 (12.1)232 (37.2)5.55 (3.78 to 8.14)<0.001
 Bad + very bad11 (0.5)39 (6.3)14.1 (5.95 to 33.4)<0.001
Cardiovascular disease0.697
 No2036 (91.5)567 (91.0)
 Yes189 (8.5)56 (9.0)
Diabetes<0.001
 No2069 (93.2)547 (87.9)1 (ref)
 Yes151 (6.8)75 (12.1)1.24 (0.82 to 1.87)0.306
Depression (CES-D)<0.001
 No2026 (93.8)404 (67.6)1 (ref)
 Yes135 (6.3)194 (32.4)3.26 (2.38 to 4.46)<0.001
Anaemia0.008
 No2151 (96.7)588 (94.4)1 (ref)
 Yes74 (3.3)35 (5.6)1.70 (1.00 to 2.89)0.049
Ferritin categories0.436
 >502016 (90.6)558 (89.6)
 Normal + low209 (9.4)65 (10.4)
TSH categories0.017
 High (>4.22)197 (8.9)56 (9.0)1.13 (0.77 to 1.66)0.533
 Normal (0.27–4.22)2015 (90.6)556 (89.3)1 (ref)
 Low (<0.27)13 (0.6)11 (1.8)2.50 (0.91 to 6.85)0.075
Free T4 categories0.651
 High (>22)47 (2.1)17 (2.7)
 Normal (12–22)2122 (95.4)591 (94.9)
 Low (<12)56 (2.5)15 (2.4)
Antihypertensives0.108
 No1550 (69.7)413 (66.3)
 Yes675 (30.3)210 (33.7)
Antihistamines0.007
 No2181 (98)599 (96.2)1 (ref)
 Yes44 (2.0)24 (3.9)1.30 (0.69 to 2.46)0.417
Antidepressants<0.001
 No2062 (92.7)508 (81.5)1 (ref)
 Yes163 (7.3)115 (18.5)1.44 (1.02 to 2.04)0.040
Hypnotics<0.001
 No2146 (96.5)580 (93.1)1 (ref)
 Yes79 (3.6)43 (6.9)0.57 (0.32 to 1.03)0.062
  • Results are expressed as the number of participants (row percentage) for the bivariate analysis and as multivariable-adjusted OR (95% CI) for the multivariable analysis. Bivariate analysis performed using χ2; multivariable analysis performed using logistic regression. Only variables with p<0.05 in the bivariate analysis were retained for the multivariable analysis.

  • –, not retained; BMI, body mass index; CES-D, Center for Epidemiologic Studies-Depression; TSH, thyroid stimulating hormone; ref, reference.